In adults, the clot-busting drugs can reduce disability if given within a few hours after stroke symptoms begin. But few studies have looked at whether the drugs are safe for children.
The study used a national database to look at all children admitted to a hospital with a diagnosis of ischemic stroke from 1998 to 2009. Only ischemic strokes can be treated with clot-busting drugs; they are the most common type of stroke.
Of the 9,367 children who were admitted with ischemic stroke, only 75 children, or 0.8 percent, received clot-busting drugs, also called thrombolytic therapy. Intracerebral hemorrhage, or bleeding in the brain, is a risk of thrombolytic therapy. The four percent rate of hemorrhage in the 75 kids who received thrombolytic therapy was higher than the 0.38 percent rate in kids who did not receive the therapy, but it was similar to the rate in adults who receive thrombolytic therapy.
Children who received thrombolytic therapy were no more likely to die following the stroke than those who did not receive the therapy.
“These findings provide evidence that clot-busting drugs can be safely used with children,” said study author Amer Alshekhlee, MD, of St. Louis University in St. Louis. “More research is needed to determine whether the drugs are as effective in preventing disability from stroke in children as they are in adults.”
The children in the study who received the therapy were older than those who did not, an average of 13 years old compared to eight years old. There were no differences in treatment regarding race, gender, or family income.
Learn more about stroke at http://www.aan.com/patients.
The American Academy of Neurology, an association of more than 25,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease and multiple sclerosis. For more information about the American Academy of Neurology, visit http://www.aan.com
Rachel L. Seroka | American Academy of Neurology
The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft
Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...
Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...
Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.
Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...
12.09.2017 | Event News
06.09.2017 | Event News
06.09.2017 | Event News
19.09.2017 | Earth Sciences
19.09.2017 | Materials Sciences
19.09.2017 | Physics and Astronomy